Paul McBarron
Director of Finance/CFO bij CYCLACEL PHARMACEUTICALS, INC.
Vermogen: 70 428 $ op 31-03-2024
Profiel
Paul McBarron is currently the CFO, COO, Secretary & Director at Cyclacel Pharmaceuticals, Inc. He previously worked as the Finance Director & Group Financial Controller at Shire Plc from 1996 to 2001.
He also served as the Director at Scottish Lifesciences Association.
Additionally, he held the position of Chief Operating Officer, Secretary & Executive VP at Cyclacel Group Plc from 2002 to 2008.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-12-2023 | 33 378 ( 2.53% ) | 70 428 $ | 31-03-2024 |
Actieve functies van Paul McBarron
| Bedrijven | Functie | Begin |
|---|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Director of Finance/CFO | 01-01-2002 |
Eerdere bekende functies van Paul McBarron
| Bedrijven | Functie | Einde |
|---|---|---|
Cyclacel Group Plc
 Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK. | Chief Operating Officer | 15-10-2008 |
| SHIRE | Director of Finance/CFO | 01-01-2001 |
Scottish Lifesciences Association
 Scottish Lifesciences Association Miscellaneous Commercial ServicesCommercial Services The Scottish Lifesciences Association operates an association for life sciences companies and organizations. | Director/Board Member | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Cyclacel Group Plc
Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK. | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Scottish Lifesciences Association
Scottish Lifesciences Association Miscellaneous Commercial ServicesCommercial Services The Scottish Lifesciences Association operates an association for life sciences companies and organizations. | Commercial Services |
